Comparative Study of Oestradiol Suppression: Zoladex 10.8mg/3 Month vs. 3.6mg/Month in ER +ve EBC Pre-menopausal Patients
Clinical trial NCT00303524 · COMPLETED
Trial details
- NCT number
- NCT00303524
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-02-01
- Primary completion
- 2007-08-01
- Enrollment
- 170
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.